The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
Abstract A model‐informed drug development approach was used to select ceftaroline fosamil high‐dose regimens for pediatric patients with complicated skin and soft‐tissue infections caused by Staphylococcus aureus with a ceftaroline minimum inhibitory concentration (MIC) of 2 or 4 mg/L. Steady‐state...
Main Authors: | Phylinda L.S. Chan, Lynn McFadyen, Andrea Quaye, Heidi Leister‐Tebbe, Victoria M. Hendrick, Jennifer Hammond, Susan Raber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12608 |
Similar Items
-
A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
by: Andrew Cristinacce, et al.
Published: (2019-04-01) -
Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience
by: Leonard B. Johnson, et al.
Published: (2019-02-01) -
Ceftaroline fosamil laden allograft: A new modality in reducing infection?
by: Vivek Ajit Singh, et al.
Published: (2018-10-01) -
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
by: Maggiore C, et al.
Published: (2015-04-01) -
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
by: Giovanni Sotgiu, et al.
Published: (2018-10-01)